Ferritin: an expanded role in metabolic regulation

Area of Science:

• Biochemistry
• Metalloprotein research
• Cellular metabolism

Background:

• Ferritin is a key protein for iron detoxification, storage, and transport, with a structure capable of sequestering significant amounts of iron.
• Ferritin's ability to bind various metal ions beyond iron, including copper, zinc, cadmium, lead, beryllium, and aluminum, is well-established.
• The protein's role extends to protecting against and reversing metal-induced enzyme inhibition, as demonstrated with beryllium.

Purpose of the Study:

• To explore the broader metal-binding capabilities of ferritin beyond iron.
• To investigate the functional consequences of ferritin's interaction with other metal ions, such as beryllium and zinc.
• To elucidate the effects of ferritin's iron release mechanisms on biomolecules and metabolic pathways.

Main Methods:

• In vitro and in vivo experiments involving ferritin and various metal ions (Fe, Be, Zn).
• Enzyme activity assays to assess the protective effects of ferritin against metal-induced inhibition.
• Incubation studies with ferritin-metal complexes and apoenzymes to evaluate functional restoration.
• Investigation of ferritin's interaction with phosphoproteins in the presence of reductants.

Main Results:

• Ferritin binds substantial quantities of beryllium (Be) in vitro and in vivo, offering protection against beryllium toxicity.
• Ferritin-zinc complexes can restore the activity of zinc-requiring apoenzymes.
• The reduction of ferritin-bound iron (Fe(III) to Fe(II)) is necessary for its release.
• In the presence of a reductant, ferritin can cause irreversible inactivation of phosphoglucomutase and other phosphoproteins, with or without phosphate loss.

Conclusions:

• Ferritin's metal-binding repertoire extends beyond iron, with significant implications for metal detoxification and homeostasis.
• The controlled release of iron from ferritin is crucial; uncontrolled release, especially in the presence of reductants and oxygen, can lead to biomolecular modification and metabolic disruption.
• Acidic isoferritins are linked to leukemia-associated inhibitory activity, suggesting a role in regulating macrophage progenitor production.